Načítá se...

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate

Small cell lung cancer (SCLC) comprises about 15% of all cases of lung cancer. In recent years, owing to a change in the epidemiology of smoking habits, the incidence of the tumor has decreased; however, it remains a significant challenge to global health. While the tumor has a favorable initial res...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drugs R D
Hlavní autoři: Lashari, Bilal H., Vallatharasu, Yazhini, Kolandra, Lakshmi, Hamid, Mohsin, Uprety, Dipesh
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277321/
https://ncbi.nlm.nih.gov/pubmed/30232719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0247-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!